BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35994850)

  • 1. Pentoxifylline attenuates nonalcoholic fatty liver by inhibiting hepatic macrophage polarization to the M1 phenotype.
    Xu D; Zhao W; Feng Y; Wen X; Liu H; Ping J
    Phytomedicine; 2022 Nov; 106():154368. PubMed ID: 35994850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
    Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
    Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
    Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
    [No Abstract]   [Full Text] [Related]  

  • 4. Yang-Xin-Shu-Mai granule alleviates atherosclerosis by regulating macrophage polarization via the TLR9/MyD88/NF-κB signaling pathway.
    Huang H; Sun Z; Xu J; Wang L; Zhao J; Li J; Zhang S; Yuan F; Liu M; Fang Z
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116868. PubMed ID: 37454749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway.
    Ye M; Tang Y; He J; Yang Y; Cao X; Kou S; Wang L; Sheng L; Xue J
    Clin Investig Arterioscler; 2021; 33(5):257-266. PubMed ID: 33810882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wuling capsule modulates macrophage polarization by inhibiting the TLR4-NF-κB signaling pathway to relieve liver fibrosis.
    Ren S; Zhou R; Tang Z; Song Z; Li N; Shi X; Liu Y; Chu Y
    Int Immunopharmacol; 2024 Mar; 129():111598. PubMed ID: 38309092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic TLR4 signaling in obese NAFLD.
    Sharifnia T; Antoun J; Verriere TG; Suarez G; Wattacheril J; Wilson KT; Peek RM; Abumrad NN; Flynn CR
    Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(4):G270-8. PubMed ID: 26113297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways.
    Shen S; Wang K; Zhi Y; Dong Y
    Pharm Biol; 2022 Dec; 60(1):1949-1959. PubMed ID: 36205541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganoderic acids alleviate atherosclerosis by inhibiting macrophage M1 polarization via TLR4/MyD88/NF-κB signaling pathway.
    Quan YZ; Ma A; Ren CQ; An YP; Qiao PS; Gao C; Zhang YK; Li XW; Lin SM; Li NN; Chen DL; Pan Y; Zhou H; Lin DM; Lin SQ; Li M; Yang BX
    Atherosclerosis; 2024 Apr; 391():117478. PubMed ID: 38417185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
    Wang L; Jia Z; Wang B; Zhang B
    Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xianglian Pill attenuates ulcerative colitis through TLR4/MyD88/NF-κB signaling pathway.
    Dai Y; Lu Q; Li P; Zhu J; Jiang J; Zhao T; Hu Y; Ding K; Zhao M
    J Ethnopharmacol; 2023 Jan; 300():115690. PubMed ID: 36075274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway.
    Shen S; Wang K; Zhi Y; Shen W; Huang L
    Cell Cycle; 2020 Nov; 19(22):3042-3053. PubMed ID: 33121337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cenicriviroc Suppresses and Reverses Steatohepatitis by Regulating Macrophage Infiltration and M2 Polarization in Mice.
    Chen G; Yu Y; Zhu Y; Nagashimada M; Wang Y; Nagata N; Xu L
    Endocrinology; 2024 May; 165(7):. PubMed ID: 38862137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling.
    Li J; Sasaki GY; Dey P; Chitchumroonchokchai C; Labyk AN; McDonald JD; Kim JB; Bruno RS
    J Nutr Biochem; 2018 Mar; 53():58-65. PubMed ID: 29190550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.
    Jiang B; Wang D; Hu Y; Li W; Liu F; Zhu X; Li X; Zhang H; Bai H; Yang Q; Yang X; Ben J; Chen Q
    Mol Metab; 2022 May; 59():101462. PubMed ID: 35247611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of berberine on proinflammatory M1 macrophage polarization through interfering with the interaction between TLR4 and MyD88.
    Gong J; Li J; Dong H; Chen G; Qin X; Hu M; Yuan F; Fang K; Wang D; Jiang S; Zhao Y; Huang W; Huang Z; Lu F
    BMC Complement Altern Med; 2019 Nov; 19(1):314. PubMed ID: 31744490
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Si MD; Wu M; Cheng XZ; Ma ZH; Zheng YG; Li J; Li S; Song YX; Ma D
    Pharm Biol; 2022 Dec; 60(1):1960-1968. PubMed ID: 36205548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-κB dependent macrophage polarization.
    Jiang Q; Li Q; Liu B; Li G; Riedemann G; Gaitantzi H; Breitkopf-Heinlein K; Zeng A; Ding H; Xu K
    Int Immunopharmacol; 2021 Jul; 96():107591. PubMed ID: 33812253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin.
    Ni Y; Nagashimada M; Zhan L; Nagata N; Kobori M; Sugiura M; Ogawa K; Kaneko S; Ota T
    Endocrinology; 2015 Mar; 156(3):987-99. PubMed ID: 25562616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease.
    Luo W; Xu Q; Wang Q; Wu H; Hua J
    Sci Rep; 2017 Mar; 7():44612. PubMed ID: 28300213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.